COMMUNIQUÉS West-GlobeNewswire

Analyse des données de phase III de Trogarzo® présentée lors d’une présentation orale de dernière heure à HIV drug therapy Glasgow 2018
31/10/2018
MONTREAL, 31 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) annonce qu’une analyse additionnelle des données de l’étude clinique de phase III de Trogarzo MD (ibalizumab-uiyk) [...]
Novo Nordisk A/S: Share repurchase programme
31/10/2018
Bagsværd, Denmark, 31 October 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Southlake Radiology Deploys Speech Recognition and Secure Healthcare Communication Platform from eRAD
31/10/2018
Tools make a difference in referring provider relationships GREENVILLE, S.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- eRAD announced today that Southlake Radiology has implemented eRAD Speech Recognition and RADAR, eRAD’s [...]
Asterias Biotherapeutics Announces Positive Outcome from Data Review from OPC1 Spinal Cord Injury Study
31/10/2018
Meeting with Food and Drug Administration Remains on Track for End of 2018 FREMONT, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to [...]
Progentec Diagnostics, Inc. Raises Funds to Support Advances in Lupus Detection and Management
31/10/2018
New funding brings lupus-detection tools closer to commercialization Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Oct. 31, 2018 (GLOBE NEWSWIRE [...]
DLT Resolution Launches DLT Internet Assurance (Automatic Failover) - Wireless Redundancy for Broadband Clients
31/10/2018
Las Vegas, NV, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DLT Resolution Inc. (OTC: DLTI), a Distributed Ledger Technology (“Blockchain”) and Information Technology company, is pleased to announce the launch [...]
Ritter Pharmaceuticals Announces Agreement for $6.0 Million At-Market Private Placement of Series B Convertible Preferred Stock and Warrants
31/10/2018
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutic products that modulate the gut microbiome to treat [...]
Alphatec Announces Participation at Stifel 2018 Healthcare Conference
31/10/2018
CARLSBAD, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative spine surgery solutions with a mission to improve patient lives through the [...]
NSS Labs Announces Results of 2018 Data Center Security Gateway Group Test
31/10/2018
Three Products Receive Recommended Rating; One Product Receives Caution Rating AUSTIN, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- NSS Labs, Inc., a global leader and trusted source for independent, fact-based [...]
Scientus Pharma Provides Update on Buccal Cannabis Development Program
31/10/2018
TORONTO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- HydRx Farms Ltd. (o/a Scientus Pharma) (“Scientus” or the “Company”), a biopharmaceutical company conducting research and product development for extracts and formulations [...]
CohBar to Announce 2018 Third Quarter Financial Results and Host Conference Call on November 14, 2018
31/10/2018
MENLO PARK, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today [...]
OncBioMune CEO Dr. Jonathan Head Speaking at 2018 Global Summit on Genitourinary Malignancies
31/10/2018
BATON ROUGE, La., Oct. 31, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]
Innovate Biopharmaceuticals Announces Participation at the Jefferies 2018 London Healthcare Conference
31/10/2018
RALEIGH, N.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and [...]
Strongbridge Biopharma plc Reports Third Quarter 2018 Financial Results and Provides Corporate Update
31/10/2018
~ Financial Position to be Significantly Strengthened in Fourth Quarter 2018 by $145 Million of Upfront Cash and $36.7 Million Equity Investment from Separately Announced Transactions with Novo Nordisk; Company Intends [...]
Golden Leaf Holdings to Hold Conference Call to Review Third Quarter 2018 Results
31/10/2018
PORTLAND, Ore., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin)
31/10/2018
~ Strongbridge to Receive Upfront Payment of $145 Million and Tiered Royalty Stream from Novo Nordisk ~ ~ Novo Nordisk to Purchase Approximately 5.2 Million Ordinary Shares of Strongbridge Biopharma plc at Purchase [...]
Marrone Bio Innovations to Report Third Quarter 2018 Financial Results on Tuesday, November 13th at 4:30 p.m. Eastern Time
31/10/2018
DAVIS, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, will release financial results for [...]
Laura Clague Named to Fluidigm Board of Directors
31/10/2018
Senior Financial Leader with Broad Corporate and Biotech Expertise SOUTH SAN FRANCISCO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Laura M. Clague to [...]
Arbutus to Report Third Quarter 2018 Financial Results
31/10/2018
WARMINSTER, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that it has scheduled its third [...]

Pages